Response to the Letter Regarding: “Prognostic Value of the Triglycerides-Glucose Index for Major-Adverse-Cardiac Events in Severe Aortic Stenosis Patients After TAVI”
Restricted accessLetterFirst published online April, 2026
Response to the Letter Regarding: “Prognostic Value of the Triglycerides-Glucose Index for Major-Adverse-Cardiac Events in Severe Aortic Stenosis Patients After TAVI”
EnginMArıH.Letter: major adverse events after transcatheter aortic valve implantation. Angiology. 2026;77(4):524-525.
2.
AltuntasETırnaksızAESadıkoğluK, et al. Prognostic value of the triglycerides-glucose index for major adverse cardiac events in severe aortic stenosis patients after TAVI. Angiology. 2026;77(4):507-514.
3.
KhawajaMZAsrressKNHaranH, et al. The effect of coronary artery disease defined by quantitative coronary angiographyand SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention. 2015;11(4):450-455.
4.
LeeSYChoiKHParkTK, et al. Impact of atrial fibrillation on patients undergoing Transcatheter Aortic Valve Implantation (TAVI): the K-TAVI Registry. Yonsei Med J. 2023;64(7):413-422.
5.
YamamotoMHayashidaKHengstenbergC, et al. Predictors of all-cause mortality after successful transcatheter aortic valve implantation in patients with atrial fibrillation. Am J Cardiol. 2023;207:150-158.
6.
RyanTGrindalAJinahR, et al. New-onset atrial fibrillation after transcatheter aortic valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2022;15(6):603-613.
